000 02564nam a22003617a 4500
008 191219s20192019 xxu||||| |||| 00| 0 eng d
022 _a2210-2612
024 _a10.1016/j.ijscr.2019.10.064 [doi]
024 _aPMC6872774 [pmc]
024 _aS2210-2612(19)30611-X [pii]
040 _aOvid MEDLINE(R)
099 _a31756689
245 _aTotal pelvic exenterative surgery in patients with peritoneal metastases from appendiceal neoplasms. A case series of 2 patients.
251 _aInternational Journal of Surgery Case Reports. 65:279-283, 2019 Nov 05.
252 _aInt J Surg Case Rep. 65:279-283, 2019 Nov 05.
253 _aInternational journal of surgery case reports
260 _c2019
260 _fFY2020
265 _saheadofprint
266 _d2019-12-17
520 _aBACKGROUND: Surgery which includes peritonectomy, visceral resections, and perioperative chemotherapy has been used extensively to treat peritoneal metastases from appendiceal mucinous adenocarcinoma. The results of treatment vary with the grade of the neoplasm, the extent of abdominal and pelvic disease and the completeness of tumor removal.
520 _aCONCLUSION: Total pelvic exenteration surgery is seldom used in patients with peritoneal metastases from appendiceal neoplasms. These two patients were studied in an attempt to determine the indications for this procedure with this disease. Copyright (c) 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.
520 _aMETHODS: The clinical features, surgical procedures and outcome of two patients with mucinous appendiceal neoplasms were reviewed. The decision to move to total pelvic exenterative surgery after prior treatment failure was critically evaluated.
520 _aRESULTS: Patient 1 had three extensive surgical procedures prior to total pelvic exenteration and one surgical procedure after. Patient 2 had one 16-h surgical procedure prior to total pelvic exenteration. Patient 1 had 8 years and 1 month survival from onset of disease until death. Patient 2 is free of disease at 27 years from onset of pseudomyxoma peritonei. After recovery of the patients from the extensive surgery, their quality of life was acceptable.
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
651 _aWashington Cancer Institute
657 _aJournal Article
700 _aSugarbaker, Paul H
790 _aSugarbaker PH
856 _uhttps://dx.doi.org/10.1016/j.ijscr.2019.10.064
_zhttps://dx.doi.org/10.1016/j.ijscr.2019.10.064
942 _cART
_dArticle
999 _c4801
_d4801